• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
MIC and time-kill study of antipneumococcal activities of RPR 106972 (a new oral streptogramin), RP 59500 (quinupristin-dalfopristin), pyostacine (RP 7293), penicillin G, cefotaxime, erythromycin, and clarithromycin against 10 penicillin-susceptible and -resistant pneumococci.RPR 106972(一种新型口服链阳菌素)、RP 59500(奎奴普丁-达福普汀)、派罗星(RP 7293)、青霉素G、头孢噻肟、红霉素和克拉霉素对10株青霉素敏感和耐药肺炎球菌的抗肺炎球菌活性的最低抑菌浓度(MIC)及时间杀菌研究。
Antimicrob Agents Chemother. 1996 Sep;40(9):2071-4. doi: 10.1128/AAC.40.9.2071.
2
Antipneumococcal activities of RP 59500 (quinupristin-dalfopristin), penicillin G, erythromycin, and sparfloxacin determined by MIC and rapid time-kill methodologies.采用最低抑菌浓度(MIC)和快速杀菌方法测定RP 59500(奎奴普丁-达福普汀)、青霉素G、红霉素和司帕沙星的抗肺炎球菌活性。
Antimicrob Agents Chemother. 1996 Jul;40(7):1653-6. doi: 10.1128/AAC.40.7.1653.
3
Study of comparative antipneumococcal activities of penicillin G, RP 59500, erythromycin, sparfloxacin, ciprofloxacin, and vancomycin by using time-kill methodology.采用时间杀菌法对青霉素G、RP 59500、红霉素、司帕沙星、环丙沙星和万古霉素的抗肺炎球菌活性进行比较研究。
Antimicrob Agents Chemother. 1994 Sep;38(9):2065-72. doi: 10.1128/AAC.38.9.2065.
4
Susceptibility of twenty penicillin-susceptible and -resistant pneumococci to levofloxacin, ciprofloxacin, ofloxacin, erythromycin, azithromycin, and clarithromycin by MIC and time-kill.通过最低抑菌浓度(MIC)和时间杀菌曲线研究20株对青霉素敏感及耐药的肺炎球菌对左氧氟沙星、环丙沙星、氧氟沙星、红霉素、阿奇霉素和克拉霉素的敏感性。
Diagn Microbiol Infect Dis. 1997 Jul;28(3):131-7. doi: 10.1016/s0732-8893(97)00017-5.
5
Susceptibility of penicillin-susceptible and -resistant pneumococci to dirithromycin compared with susceptibilities to erythromycin, azithromycin, clarithromycin, roxithromycin, and clindamycin.与对红霉素、阿奇霉素、克拉霉素、罗红霉素和克林霉素的敏感性相比,青霉素敏感和耐药肺炎球菌对地红霉素的敏感性。
Antimicrob Agents Chemother. 1997 Sep;41(9):1867-70. doi: 10.1128/AAC.41.9.1867.
6
MIC and time-kill study of activities of DU-6859a, ciprofloxacin, levofloxacin, sparfloxacin, cefotaxime, imipenem, and vancomycin against nine penicillin-susceptible and -resistant pneumococci.DU-6859a、环丙沙星、左氧氟沙星、司帕沙星、头孢噻肟、亚胺培南及万古霉素对9株青霉素敏感及耐药肺炎球菌活性的最低抑菌浓度(MIC)及时间杀菌研究
Antimicrob Agents Chemother. 1996 Feb;40(2):362-6. doi: 10.1128/AAC.40.2.362.
7
Comparative activities of clarithromycin, erythromycin, and azithromycin against penicillin-susceptible and penicillin-resistant pneumococci.克拉霉素、红霉素和阿奇霉素对青霉素敏感及耐药肺炎球菌的比较活性
Antimicrob Agents Chemother. 1996 Aug;40(8):1950-2. doi: 10.1128/AAC.40.8.1950.
8
Susceptibilities of penicillin- and erythromycin-susceptible and -resistant pneumococci to HMR 3647 (RU 66647), a new ketolide, compared with susceptibilities to 17 other agents.将青霉素敏感及耐药、红霉素敏感及耐药的肺炎球菌对新型酮内酯类药物HMR 3647(RU 66647)的敏感性与对其他17种药物的敏感性进行比较。
Antimicrob Agents Chemother. 1998 Mar;42(3):624-30. doi: 10.1128/AAC.42.3.624.
9
Antipneumococcal activity of AZD2563, a new oxazolidinone, compared with nine other agents.新型恶唑烷酮类药物AZD2563与其他九种药物的抗肺炎球菌活性比较。
J Antimicrob Chemother. 2002 Jul;50(1):95-100. doi: 10.1093/jac/dkf080.
10
Activities of a new oral streptogramin, XRP 2868, compared to those of other agents against Streptococcus pneumoniae and haemophilus species.新型口服链阳菌素XRP 2868与其他药物相比,对肺炎链球菌和嗜血杆菌属的活性。
Antimicrob Agents Chemother. 2003 Oct;47(10):3270-4. doi: 10.1128/AAC.47.10.3270-3274.2003.

引用本文的文献

1
Time-kill study of the activity of telithromycin against macrolide-resistant Streptococcus pneumoniae Isolates with 23S rRNA mutations and changes in ribosomal proteins L4 and L22.泰利霉素对具有23S rRNA突变及核糖体蛋白L4和L22改变的大环内酯类耐药肺炎链球菌分离株活性的时间杀菌研究
Antimicrob Agents Chemother. 2005 Jul;49(7):3011-3. doi: 10.1128/AAC.49.7.3011-3013.2005.
2
Quinupristin/dalfopristin: a review of its use in the management of serious gram-positive infections.奎奴普丁/达福普汀:用于治疗严重革兰氏阳性菌感染的综述
Drugs. 1999 Dec;58(6):1061-97. doi: 10.2165/00003495-199958060-00008.
3
Diminished killing of pneumococci by pristinamycin demonstrated by time-kill studies.时间杀菌研究表明,普那霉素对肺炎球菌的杀菌作用减弱。
Antimicrob Agents Chemother. 1999 Aug;43(8):2099-100. doi: 10.1128/AAC.43.8.2099.
4
Streptogramins and their potential role in geriatric medicine.链阳菌素及其在老年医学中的潜在作用。
Drugs Aging. 1998 Dec;13(6):443-65. doi: 10.2165/00002512-199813060-00004.
5
Management of infections due to antibiotic-resistant Streptococcus pneumoniae.耐抗生素肺炎链球菌所致感染的管理
Clin Microbiol Rev. 1998 Oct;11(4):628-44. doi: 10.1128/CMR.11.4.628.
6
In vitro activities of quinupristin-dalfopristin and the streptogramin RPR 106972 against Mycoplasma pneumoniae.喹奴普丁-达福普汀及链阳性菌素RPR 106972对肺炎支原体的体外活性
Antimicrob Agents Chemother. 1998 Mar;42(3):698-9. doi: 10.1128/AAC.42.3.698.
7
Influence of inducible cross-resistance to macrolides, lincosamides, and streptogramin B-type antibiotics in Enterococcus faecium on activity of quinupristin-dalfopristin in vitro and in rabbits with experimental endocarditis.粪肠球菌对大环内酯类、林可酰胺类和链阳菌素B型抗生素的诱导性交叉耐药性对奎奴普丁-达福普汀体外活性及兔实验性心内膜炎模型活性的影响。
Antimicrob Agents Chemother. 1997 May;41(5):931-5. doi: 10.1128/AAC.41.5.931.

本文引用的文献

1
Activities of RPR 106972 (a new oral streptogramin), cefditoren (a new oral cephalosporin), two new oxazolidinones (U-100592 and U-100766), and other oral and parenteral agents against 203 penicillin-susceptible and -resistant pneumococci.RPR 106972(一种新型口服链阳菌素)、头孢妥仑(一种新型口服头孢菌素)、两种新型恶唑烷酮(U-100592和U-100766)以及其他口服和胃肠外用药对203株青霉素敏感和耐药肺炎球菌的活性。
Antimicrob Agents Chemother. 1996 Feb;40(2):481-4. doi: 10.1128/AAC.40.2.481.
2
MIC and time-kill study of activities of DU-6859a, ciprofloxacin, levofloxacin, sparfloxacin, cefotaxime, imipenem, and vancomycin against nine penicillin-susceptible and -resistant pneumococci.DU-6859a、环丙沙星、左氧氟沙星、司帕沙星、头孢噻肟、亚胺培南及万古霉素对9株青霉素敏感及耐药肺炎球菌活性的最低抑菌浓度(MIC)及时间杀菌研究
Antimicrob Agents Chemother. 1996 Feb;40(2):362-6. doi: 10.1128/AAC.40.2.362.
3
Antipneumococcal activities of RP 59500 (quinupristin-dalfopristin), penicillin G, erythromycin, and sparfloxacin determined by MIC and rapid time-kill methodologies.采用最低抑菌浓度(MIC)和快速杀菌方法测定RP 59500(奎奴普丁-达福普汀)、青霉素G、红霉素和司帕沙星的抗肺炎球菌活性。
Antimicrob Agents Chemother. 1996 Jul;40(7):1653-6. doi: 10.1128/AAC.40.7.1653.
4
Emergence of multiple-antibiotic-resistant Streptococcus pneumoniae in Hong Kong.香港多重耐药肺炎链球菌的出现。
Antimicrob Agents Chemother. 1995 Dec;39(12):2667-70. doi: 10.1128/AAC.39.12.2667.
5
Activity of oral antibiotics in middle ear and sinus infections caused by penicillin-resistant Streptococcus pneumoniae: implications for treatment.口服抗生素对耐青霉素肺炎链球菌引起的中耳和鼻窦感染的活性:对治疗的启示
Pediatr Infect Dis J. 1994 Jul;13(7):585-9. doi: 10.1097/00006454-199407000-00001.
6
In vitro activities of 12 orally administered antimicrobial agents against four species of bacterial respiratory pathogens from U.S. Medical Centers in 1992 and 1993.1992年和1993年12种口服抗菌药物对来自美国医疗中心的四种细菌性呼吸道病原体的体外活性。
Antimicrob Agents Chemother. 1994 Oct;38(10):2419-25. doi: 10.1128/AAC.38.10.2419.
7
Study of comparative antipneumococcal activities of penicillin G, RP 59500, erythromycin, sparfloxacin, ciprofloxacin, and vancomycin by using time-kill methodology.采用时间杀菌法对青霉素G、RP 59500、红霉素、司帕沙星、环丙沙星和万古霉素的抗肺炎球菌活性进行比较研究。
Antimicrob Agents Chemother. 1994 Sep;38(9):2065-72. doi: 10.1128/AAC.38.9.2065.
8
The prevalence of drug-resistant Streptococcus pneumoniae in Atlanta.亚特兰大耐青霉素肺炎链球菌的患病率。
N Engl J Med. 1995 Aug 24;333(8):481-6. doi: 10.1056/NEJM199508243330803.
9
Pneumococcal resistance to antibiotics.肺炎球菌对抗生素的耐药性。
Clin Microbiol Rev. 1990 Apr;3(2):171-96. doi: 10.1128/CMR.3.2.171.
10
Intercontinental spread of a multiresistant clone of serotype 23F Streptococcus pneumoniae.23F血清型肺炎链球菌多重耐药克隆株的洲际传播。
J Infect Dis. 1991 Aug;164(2):302-6. doi: 10.1093/infdis/164.2.302.

RPR 106972(一种新型口服链阳菌素)、RP 59500(奎奴普丁-达福普汀)、派罗星(RP 7293)、青霉素G、头孢噻肟、红霉素和克拉霉素对10株青霉素敏感和耐药肺炎球菌的抗肺炎球菌活性的最低抑菌浓度(MIC)及时间杀菌研究。

MIC and time-kill study of antipneumococcal activities of RPR 106972 (a new oral streptogramin), RP 59500 (quinupristin-dalfopristin), pyostacine (RP 7293), penicillin G, cefotaxime, erythromycin, and clarithromycin against 10 penicillin-susceptible and -resistant pneumococci.

作者信息

Pankuch G A, Jacobs M R, Appelbaum P C

机构信息

Department of Pathology (Clinical Microbiology), Hershey Medical Center, Pennsylvania 17033, USA.

出版信息

Antimicrob Agents Chemother. 1996 Sep;40(9):2071-4. doi: 10.1128/AAC.40.9.2071.

DOI:10.1128/AAC.40.9.2071
PMID:8878583
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC163475/
Abstract

Broth MICs and time-kill studies were used to test the activity of RP 59500 (quinupristin-dalfopristin), RPR 106972, pyostacine (RP 7293), erythromycin, clarithromycin, and cefotaxime for four penicillin-susceptible (MICs of 0.008 to 0.03 microgram/ml), two penicillin-intermediate (MIC of 0.25 microgram/ml), and four penicillin-resistant (MIC of 2.0 to 4.0 micrograms/ml) strains of pneumococci: 6 of 10 strains were resistant to macrolides (MICs of > or = 0.5 microgram/ml). MICs of RP 59500 (0.5 to 1.0 microgram/ml), RPR 106972 (0.125 to 0.25 microgram/ml), and pyostacine (0.125 to 0.25 microgram/ml) did not alter with the strain's penicillin or macrolide susceptibility status. Three penicillin-susceptible strains and one penicillin-intermediate strain were susceptible to macrolides (MICs of < or = 0.25 microgram/ml); the macrolide MICs for the remaining strains were > or = 4.0 micrograms/ml. Cefotaxime MICs rose with those of penicillin G, but all strains were inhibited at MICs of < or = 2.0 micrograms/ml. RP 59500 was bactericidal for all strains after 24 h at 2 x MIC and yielded 90% killing of all strains at 6 h at 2 x MIC; at 8 x MIC, RP 59500 showed 90% killing of six strains within 10 min (approximately 0.2 h). In comparison, RPR 106972 was bactericidal for 9 of 10 strains at 2 x MIC after 24 h and yielded 90% killing of all strains at 2 x MIC after 6 h; 90% killing of six strains was found at 8 x MIC at 0.2 h. Results for pyostacine were similar to those of RPR 106972. Erythromycin and clarithromycin were bactericidal for three of four macrolide-susceptible strains after 24 h at 4 x MIC. Clarithromycin yielded 90% killing of three strains at 8 x MIC after 12 h. Cefotaxime was bactericidal for all strains after 24 h at 4 x MIC, yielding 90% killing of all strains after 6 h at 4 x MIC. All three streptogramins yielded rapid killing of penicillin- and erythromycin-susceptible and -resistant pneumococci and were the only compounds which killed significant numbers of strains at 0.2 h.

摘要

采用肉汤稀释法测定最低抑菌浓度(MIC)以及时间杀菌试验,以检测RP 59500(喹奴普汀-达福普汀)、RPR 106972、派罗星(RP 7293)、红霉素、克拉霉素和头孢噻肟对4株青霉素敏感(MIC为0.008至0.03微克/毫升)、2株青霉素中介(MIC为0.25微克/毫升)和4株青霉素耐药(MIC为2.0至4.0微克/毫升)肺炎球菌菌株的活性:10株菌株中有6株对大环内酯类耐药(MIC≥0.5微克/毫升)。RP 59500(0.5至1.0微克/毫升)、RPR 106972(0.125至0.25微克/毫升)和派罗星(0.125至0.25微克/毫升)的MIC不会因菌株的青霉素或大环内酯类敏感性状态而改变。3株青霉素敏感菌株和1株青霉素中介菌株对大环内酯类敏感(MIC≤0.25微克/毫升);其余菌株的大环内酯类MIC≥4.0微克/毫升。头孢噻肟的MIC随青霉素G的MIC升高而升高,但所有菌株在MIC≤2.0微克/毫升时均受到抑制。RP 59500在2倍MIC浓度下作用24小时后对所有菌株均有杀菌作用,在2倍MIC浓度下作用6小时后对所有菌株的杀菌率达90%;在8倍MIC浓度下,RP 59500在10分钟(约0.2小时)内对6株菌株的杀菌率达90%。相比之下,RPR 106972在2倍MIC浓度下作用24小时后对10株菌株中的9株有杀菌作用,在2倍MIC浓度下作用6小时后对所有菌株的杀菌率达90%;在8倍MIC浓度下,0.2小时时对6株菌株的杀菌率达90%。派罗星的结果与RPR 106972相似。红霉素和克拉霉素在4倍MIC浓度下作用24小时后对4株大环内酯类敏感菌株中的3株有杀菌作用。克拉霉素在8倍MIC浓度下作用12小时后对3株菌株的杀菌率达90%。头孢噻肟在4倍MIC浓度下作用24小时后对所有菌株均有杀菌作用,在4倍MIC浓度下作用6小时后对所有菌株的杀菌率达90%。所有三种链阳菌素对青霉素和红霉素敏感及耐药的肺炎球菌均有快速杀菌作用,并且是仅有的在0.2小时内就能杀死大量菌株的化合物。